Kintor Pharmaceutical Limited (9939.HK)
HKD 1.31
(9.17%)
HKD 1.31
(9.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -42.22 Million CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 34.23 Thousand CNY | 0.0% |
| 2020 | - CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 9.00 CNY | -99.99% |
| 2017 | 139.75 Thousand CNY | -87.15% |
| 2016 | 1.08 Million CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | -42.22 Thousand CNY | 0.0% |
| 2023 Q2 | - CNY | 0.0% |
| 2023 FY | -42.22 Million CNY | 0.0% |
| 2022 FY | - CNY | -100.0% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 Q2 | - CNY | -100.0% |
| 2021 FY | 34.23 Thousand CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q4 | 34.23 Thousand CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2018 FY | 9.00 CNY | -99.99% |
| 2017 FY | 139.75 Thousand CNY | -87.15% |
| 2017 Q4 | 150.19 CNY | 1539.69% |
| 2017 Q2 | -10.43 CNY | -103.96% |
| 2016 Q4 | 263.49 CNY | -68.04% |
| 2016 Q2 | 824.50 CNY | 0.0% |
| 2016 FY | 1.08 Million CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 110.75% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 104.456% |